Reuters logo
BRIEF-Synthetic Biologics says granted U.S. composition of matter patent for SYN-005
December 13, 2016 / 12:18 PM / 9 months ago

BRIEF-Synthetic Biologics says granted U.S. composition of matter patent for SYN-005

Dec 13 (Reuters) - Synthetic Biologics Inc

* Synthetic Biologics announces granting of U.S. composition of matter patent for SYN-005, designed for the treatment and prevention of pertussis (whooping cough) Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below